SCHEMBL24944734

SCHEMBL24944734

O=C(OC1CC2(C1)CN(Cc1ccccc1)C2)N1CCN(c2ncc(N3CCC3=O)cn2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.40
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
USP2 O75604 2/20 0.40
CHRM2 P08172 2/20 0.40
CHRM1 P11229 1/20 0.40
CHRM4 P08173 4/20 0.40
HTR7 P34969 1/20 0.39
CYP2D6 P10635 5/20 0.39
TSHR P16473 1/20 0.39
HRH3 Q9Y5N1 2/20 0.39
MGLL Q99685 1/20 0.38
MAPK1 P28482 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRL1 P41146 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31492289 0.87 CHRM2 (0.44) CHRM2CHRM1CHRM4
SCHEMBL24945761 0.86 HTR7 (0.44) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL23744120 0.86 CYP2D6 (0.45) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL23744809 0.84 CYP2D6 (0.42) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL26089375 0.83 CYP3A4 (0.46) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL26087084 0.83 CHRM2 (0.56) CYP3A4CYP1A2USP2CHRM2CHRM1
SCHEMBL24945665 0.83 MAPK1 (0.45) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL24945637 0.82 CYP3A4 (0.41) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL31492306 0.82 CHRM2 (0.43) CHRM2CHRM1CHRM4
SCHEMBL24944794 0.82 ALDH1A1 (0.40) CYP3A4ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010078-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2023-02-02 WO disclosed